Table 2.
ApoJ means and standard deviations for stratified subgroup analyses
| Categories | Mean (SD) |
|||||
|---|---|---|---|---|---|---|
| HC mean (SD) |
MCI mean (SD) |
AD mean (SD) |
||||
| Baseline | 18 mo | Baseline | 18 mo | Baseline | 18 mo | |
| Total | 283.76 (38.98) | 289.8 (39.63) | 327.33 (41.41) | 342.58 (40.87) | 347.17 (42.09) | 349.38 (38.91) |
| APOE ε4 −ve | 283.69 (39.58) | 290.9 (39.94) | 328.33 (37.61) | 344.27 (42.74) | 343.03 (43.22) | 350.03 (41.36) |
| APOE ε4 +ve | 283.92 (37.78) | 287.4 (38.94) | 326.44 (44.92) | 340.31 (38.83) | 349.31 (41.55) | 349.07 (37.88) |
| Female | 282.13 (37.72) | 290.82 (40.2) | 323.96 (43.78) | 346.32 (42.91) | 347.04 (45.07) | 347.16 (39.51) |
| Male | 285.91 (40.55) | 288.41 (38.87) | 331.6 (38.3) | 338.13 (38.49) | 347.36 (37.81) | 352.56 (38.08) |
| Age | ||||||
| <65 | 282.92 (36.65) | 290.75 (41.29) | 316.3 (51.12) | 326.75 (45.23) | 351.31 (36.9) | 346.7 (39.36) |
| 65–75 | 283.78 (39.89) | 289.08 (38.45) | 333.82 (41.66) | 343.69 (40.44) | 347.94 (45.56) | 354.66 (33.77) |
| 75–85 | 286.22 (40.44) | 293.49 (40.89) | 323.61 (40.42) | 341.09 (42.6) | 347.74 (39.83) | 352.68 (37.22) |
| >85 | 272.24 (31.3) | 272.65 (36.66) | 329.86 (40.72) | 354.86 (36.01) | 343.3 (45.61) | 343.62 (42.59) |
Abbreviations: APoJ, apolipoprotein J; SD, standard deviation; HC, healthy control; MCI, mild cognitive impairment; AD, Alzheimer's disease; APOE ε4, apolipoprotein ε4.
NOTE. NA means not enough participants in group to calculate mean and standard deviation.